Names | |
---|---|
IUPAC name
N-Methyl-N-(phosphonocarbamimidoyl)glycine
| |
Other names
Creatine phosphate; phosphorylcreatine; creatine-P; phosphagen; fosfocreatine
| |
Identifiers | |
3D model (JSmol)
|
|
Abbreviations | PCr |
1797096 | |
ChEBI | |
ChEMBL | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.000.585 |
EC Number |
|
KEGG |
|
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C4H10N3O5P | |
Molar mass | 211.114 g·mol−1 |
Pharmacology | |
C01EB06 (WHO) | |
Hazards | |
GHS labelling: | |
Warning | |
H315, H319, H335 | |
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Phosphocreatine, also known as creatine phosphate (CP) or PCr (Pcr), is a phosphorylated form of creatine that serves as a rapidly mobilizable reserve of high-energy phosphates in skeletal muscle, myocardium and the brain to recycle adenosine triphosphate, the energy currency of the cell.